These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 32882421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
    Andreas CJ, Chen YC, Markopoulos C, Reppas C, Dressman J.
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
    [Abstract] [Full Text] [Related]

  • 3. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.
    Mann J, Dressman J, Rosenblatt K, Ashworth L, Muenster U, Frank K, Hutchins P, Williams J, Klumpp L, Wielockx K, Berben P, Augustijns P, Holm R, Hofmann M, Patel S, Beato S, Ojala K, Tomaszewska I, Bruel JL, Butler J.
    Mol Pharm; 2017 Dec 04; 14(12):4192-4201. PubMed ID: 28737403
    [Abstract] [Full Text] [Related]

  • 4. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
    Andreas CJ, Tomaszewska I, Muenster U, van der Mey D, Mueck W, Dressman JB.
    Eur J Pharm Biopharm; 2016 Aug 04; 105():193-202. PubMed ID: 27322002
    [Abstract] [Full Text] [Related]

  • 5. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests.
    Yamaguchi Ikeuchi S, Kambayashi A, Kojima H, Oku N, Asai T.
    Biol Pharm Bull; 2018 Aug 04; 41(11):1708-1715. PubMed ID: 30381671
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic investigation of the negative food effect of modified release zolpidem.
    Andreas CJ, Pepin X, Markopoulos C, Vertzoni M, Reppas C, Dressman JB.
    Eur J Pharm Sci; 2017 May 01; 102():284-298. PubMed ID: 28286289
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197.
    Schilderink R, Protopappa M, Fleth-James J, Vertzoni M, Schaefer K, Havenaar R, Kulla I, Metzger M, Reppas C.
    Eur J Pharm Biopharm; 2020 Apr 01; 149():154-162. PubMed ID: 32057905
    [Abstract] [Full Text] [Related]

  • 9. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
    Berben P, Ashworth L, Beato S, Bevernage J, Bruel JL, Butler J, Dressman J, Schäfer K, Hutchins P, Klumpp L, Mann J, Nicolai J, Ojala K, Patel S, Powell S, Rosenblatt K, Tomaszewska I, Williams J, Augustijns P.
    Eur J Pharm Biopharm; 2019 Jul 01; 140():141-148. PubMed ID: 31051249
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media.
    Nurhikmah W, Sumirtapura YC, Pamudji JS.
    Sci Pharm; 2016 Jul 01; 84(1):181-90. PubMed ID: 27110508
    [Abstract] [Full Text] [Related]

  • 15. Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.
    Guimarães M, Somville P, Vertzoni M, Fotaki N.
    AAPS J; 2022 Jan 10; 24(1):26. PubMed ID: 35013835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA, Faisal W, O'Shea JP, Murphy C, Ahern RJ, Ryan KB, Griffin BT, Crean AM.
    J Control Release; 2017 Mar 28; 250():86-95. PubMed ID: 28132935
    [Abstract] [Full Text] [Related]

  • 18. Novel dissolution methods for drug release testing of Long-Acting injectables.
    Malavia N, Bao Q, Burgess DJ.
    Int J Pharm; 2024 Oct 25; 664():124634. PubMed ID: 39182741
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.